These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overview of age-related ocular conditions. Akpek EK; Smith RA Am J Manag Care; 2013 May; 19(5 Suppl):S67-75. PubMed ID: 23725498 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. Brennan LA; Kantorow M Exp Eye Res; 2009 Feb; 88(2):195-203. PubMed ID: 18588875 [TBL] [Abstract][Full Text] [Related]
4. Tearful relations: oxidative stress, inflammation and eye diseases. Wakamatsu TH; Dogru M; Tsubota K Arq Bras Oftalmol; 2008; 71(6 Suppl):72-9. PubMed ID: 19274416 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and the eye. Williams DL Vet Clin North Am Small Anim Pract; 2008 Jan; 38(1):179-92, vii. PubMed ID: 18249249 [TBL] [Abstract][Full Text] [Related]
6. The Eye, Oxidative Damage and Polyunsaturated Fatty Acids. Saccà SC; Cutolo CA; Ferrari D; Corazza P; Traverso CE Nutrients; 2018 May; 10(6):. PubMed ID: 29795004 [TBL] [Abstract][Full Text] [Related]
7. Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease. Dogru M; Kojima T; Simsek C; Tsubota K Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES163-DES168. PubMed ID: 30481822 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of melatonin in experimental free radical-related ocular diseases. Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546 [TBL] [Abstract][Full Text] [Related]
9. The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases. Hsueh YJ; Chen YN; Tsao YT; Cheng CM; Wu WC; Chen HC Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163178 [TBL] [Abstract][Full Text] [Related]
10. Searching for the Antioxidant, Anti-Inflammatory, and Neuroprotective Potential of Natural Food and Nutritional Supplements for Ocular Health in the Mediterranean Population. Valero-Vello M; Peris-Martínez C; García-Medina JJ; Sanz-González SM; Ramírez AI; Fernández-Albarral JA; Galarreta-Mira D; Zanón-Moreno V; Casaroli-Marano RP; Pinazo-Duran MD Foods; 2021 May; 10(6):. PubMed ID: 34071459 [TBL] [Abstract][Full Text] [Related]
11. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique. Babizhayev MA; Yegorov YE Recent Pat Drug Deliv Formul; 2016; 10(2):82-129. PubMed ID: 26084629 [TBL] [Abstract][Full Text] [Related]
12. [Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia]. Tsubota K Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):232-48. PubMed ID: 30088407 [TBL] [Abstract][Full Text] [Related]
13. From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment. Dammak A; Huete-Toral F; Carpena-Torres C; Martin-Gil A; Pastrana C; Carracedo G Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575451 [TBL] [Abstract][Full Text] [Related]
14. The Role Oxidative Stress in the Pathogenesis of Eye Diseases: Current Status and a Dual Role of Physical Activity. Kruk J; Kubasik-Kladna K; Aboul-Enein HY Mini Rev Med Chem; 2015; 16(3):241-57. PubMed ID: 26586128 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine. Babizhayev MA Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446 [TBL] [Abstract][Full Text] [Related]
16. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases. Babizhayev MA; Kasus-Jacobi A Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498 [TBL] [Abstract][Full Text] [Related]